As can be seen, compared with healthy tissues, RBCK1 is significantly higher in breast cancer patient specimens compared to other molecular types of breast cancer samples, whereby RBCK1 is expressed more in ER-positive breast cancer (Fig. 4A, B, https://www.oncomine.org). Here, RBCK1 is linked to breast carcinoma.